C. Kenneth

A real-world, long-term experience on effectiveness and safety of vedolizumab in adult patients with inflammatory bowel disease: The Cross Pennine study.

C. Stansfield, C. Selinger, J. Limdi, 2018, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

P147 Safety and efficacy of ustekinumab for Crohn’s disease (CD): the cross pennine experience

Rachael C. Walker, C. Stansfield, C. Selinger, 2021, Posters.

A propensity score‐matched, real‐world comparison of ustekinumab vs vedolizumab as a second‐line treatment for Crohn’s disease. The Cross Pennine study II

A. de Silvestri, C. Stansfield, C. Selinger, 2021, Alimentary pharmacology & therapeutics.

P525 Effectiveness and safety of vedolizumab in IBD patients: a multicentre experience of "real world data" from the UK.

C. Stansfield, C. Selinger, P. Hamlin, 2017, Journal of Crohn's & colitis.